Keros Therapeutics, Inc. ($KROS)
Filing Information
| Accession Number | 0001721020-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 5, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
14,575
Total Value
$0.00
P&L
+inf% (+$155,078.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 3, 2026 | Grant/Award | 7,142 | $0.00 | $0.00 | 12,392 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jun 3, 2026 | Grant/Award | 7,433 | $0.00 | $0.00 | 7,433 | Direct | โ | View Details |